Good results seen with SIBS microshunt at 3 years

NASHVILLE, Tenn. — Patients with open-angle glaucoma had favorable outcome 3 years after undergoing stand-alone SIBS microshunt implantation, according to a study.
“The SIBS microshunt is an implantable glaucoma device made from the same bioinert, non-reactive material that is found in coronary artery stents,” James J. Armstrong, MD, PhD, said at the American Glaucoma Society meeting. “There are two important elements to its design. First, its 7-µm lumen and 8.5 mm length were engineered to limit outflow at lower IOPs, reducing hypotony risk. Second, the device has two

NASHVILLE, Tenn. — Patients with open-angle glaucoma had favorable outcome 3 years after undergoing stand-alone SIBS microshunt implantation, according to a study.
“The SIBS microshunt is an implantable glaucoma device made from the same bioinert, non-reactive material that is found in coronary artery stents,” James J. Armstrong, MD, PhD, said at the American Glaucoma Society meeting. “There are two important elements to its design. First, its 7-µm lumen and 8.5 mm length were engineered to limit outflow at lower IOPs, reducing hypotony risk. Second, the device has two